Positions

Overview

  • Dr. Walsh joins our faculty following a two year fellowship in Otology/Neurotology at the Michigan Ear Institute. She earned her medical degree from Harvard Medical School and completed her residency with us here at UAB. Dr. McGrew had the pleasure of training Erika throughout her residency and advocated for her recruitment, recognizing her skill in managing both common and complex conditions of the ear, temporal bone and lateral skull base. Dr. Walsh is currently accepting new patients and her clinic opens mid-August 2019.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Current management of superior semicircular canal dehiscence syndrome.  Current Opinion in Otolaryngology and Head and Neck Surgery.  28:340-345. 2020
    2020 Perioperative Pain Management Following Otologic Surgery.  Otolaryngologic Clinics of North America.  53:803-810. 2020
    2019 Fluorescence Imaging of Nerves during Surgery.  Annals of Surgery.  270:69-76. 2019
    2019 Phosphaturic Mesenchymal Tumor of the Cerebellopontine Angle.  JAMA Otolaryngology-Head and Neck Surgery.  145:287-288. 2019
    2018 Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer.  Surgical Oncology.  27:225-230. 2018
    2017 Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma 2017
    2017 Characterizing the utility and limitations of repurposing an open-field optical imaging device for fluorescence-guided surgery in head and neck cancer patients.  Journal of Nuclear Medicine.  58:246-251. 2017
    2016 Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment.  Journal of Pathology: Clinical Research.  2:104-112. 2016
    2015 Inaccurate Assessments of Anterior Cranial Base Malignancy Following Nasoseptal Flap Reconstruction.  Journal of Neurological Surgery Part B: Skull Base.  76:385-389. 2015
    2015 Nutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation.  Biochemical and Biophysical Research Communications.  461:293-299. 2015
    2015 Shaping the Future of Research: A perspective from junior scientists.  F1000Research.  3. 2015
    2015 The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains.  Genes and Development.  29:1507-1523. 2015
    2014 MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.  Oncogene.  33:1736-1742. 2014
    2014 ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis.  Oncogene.  33:212-224. 2014
    2014 NSD3-NUT fusion oncoprotein in NUT midline carcinoma: Implications for a novel oncogenic mechanism.  Cancer Discovery.  4:929-941. 2014
    2014 ΔNp63α activates CD82 metastasis suppressor to inhibit cancer cell invasion.  Cell Death and Disease.  5. 2014
    2013 Epidemiology and differential diagnosis of nasal polyps 2013
    2009 Nutlin-3 affects expression and function of retinoblastoma protein. Role of Retinoblastoma protein in cellular response to nutlin-3.  Journal of Biological Chemistry.  284:26315-26321. 2009
    2008 Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.  Oncogene.  27:4034-4043. 2008

    Education And Training

  • Doctor of Medicine, Harvard University 2012
  • Bachelor of Arts in Psychology, Yale University 2008

    • Full Name

  • Erika Walsh